The 2025 Revisions to the Pharmaceuticals and Medical Devices Act ― Impact on the Life Sciences and Healthcare Industry and Remaining Challenges ―
- Kensuke Suzuki
- Masanori Tosu
- Tomoharu Hagiwara
Nagashima Ohno & Tsunematsu Tokyo Office
- Pharmaceutical and Healthcare
- Medical, Pharmaceutical and Life Sciences